Medical
Industry Group
NVCA's Healthcare Reform Principles 
Patent Reform - June, 2008
Abbreviated FDA Approval Pathway for Follow-on Biologics (FOBs) - June, 2008
Government Regulation Impacting the Development of Medical Innovation, FDA and CMS Process Reform- June, 2008
NVCA Letter on HR5629 - Pathway Biosimilar Act - May 16, 2008
NVCA Letter on Follow-on Biologics - May 2, 2008
NVCA Congressional Testimony on SBIR Reauthorization - March 13, 2008
Presentation:
President’s Council of Advisors on Science and Technology,
Personalized Medicine Subcommittee - January 9, 2008
NVCA
Letter to Senators Leahy and Specter on Patent Reform -
November 6, 2007
Patent
Reform Position Paper - Updated Oct. 2007
House
Small Business Committee Hearing - Patent Reform Impact
on Small Venture-backed Companies (March 29, 2007)
Proposal
for a Reimbursement "Critical Path" for CMS
Substantial
Clinical Improvement Requirement for New Technology Add-On
Payments
NVCA
Comments on Coverage with Evidence Development Guidance
NVCA
White Paper on the Future of Government Innovation
